MA39204A1 - Heteroaryl derivatives inhibiting vps34 and / or p13 for the treatment of proliferative, inflammatory or cardiovascular disorders - Google Patents
Heteroaryl derivatives inhibiting vps34 and / or p13 for the treatment of proliferative, inflammatory or cardiovascular disordersInfo
- Publication number
- MA39204A1 MA39204A1 MA39204A MA39204A MA39204A1 MA 39204 A1 MA39204 A1 MA 39204A1 MA 39204 A MA39204 A MA 39204A MA 39204 A MA39204 A MA 39204A MA 39204 A1 MA39204 A1 MA 39204A1
- Authority
- MA
- Morocco
- Prior art keywords
- inflammatory
- proliferative
- cardiovascular disorders
- treatment
- heteroaryl derivatives
- Prior art date
Links
Abstract
La présente invention concerne un composé de formule i : et des sels pharmaceutiquement acceptables dudit composé, x, r1, r2, r3, r4, r5, l1, l2, m, et n étant tels que décrits dans la description. Lesdits composés sont des inhibiteurs de vps34 et/ou de p13 et sont utilisés pour traiter des troubles prolifératifs, inflammatoires ou cardiovasculaires.The present invention relates to a compound of formula I: and pharmaceutically acceptable salts of said compound, x, r1, r2, r3, r4, r5, ll, 12, m, and n being as described in the description. The compounds are inhibitors of vps34 and / or p13 and are used to treat proliferative, inflammatory or cardiovascular disorders.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461927055P | 2014-01-14 | 2014-01-14 | |
PCT/US2015/011191 WO2015108861A1 (en) | 2014-01-14 | 2015-01-13 | Heteroaryls and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
MA39204A1 true MA39204A1 (en) | 2017-11-30 |
MA39204B1 MA39204B1 (en) | 2019-04-30 |
Family
ID=58698453
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA39204A MA39204B1 (en) | 2014-01-14 | 2015-01-13 | Heteroaryl derivatives inhibiting vps34 and / or p13 for the treatment of proliferative, inflammatory or cardiovascular disorders |
Country Status (2)
Country | Link |
---|---|
AR (1) | AR099093A1 (en) |
MA (1) | MA39204B1 (en) |
-
2015
- 2015-01-13 MA MA39204A patent/MA39204B1/en unknown
- 2015-01-14 AR ARP150100091A patent/AR099093A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
MA39204B1 (en) | 2019-04-30 |
AR099093A1 (en) | 2016-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12016502382A1 (en) | Substituted indazole compounds as irak4 inhibitors | |
PH12018500041A1 (en) | Substituted aza compoounds as irak-4 inhibitors | |
EA201650031A1 (en) | DERIVATIVES PYRROLIDIN-2,5-DIONA, PHARMACEUTICAL COMPOSITIONS AND METHODS OF APPLICATION AS IDO1 INHIBITORS | |
MX2018010192A (en) | Glycosidase inhibitors. | |
PH12020551014A1 (en) | Amino-fluoropiperidine derivatives as kinase inhibitor | |
PH12016501388A1 (en) | Heteroaryls and uses thereof | |
MX2016016516A (en) | Phosphatidylinositol 3-kinase inhibitors. | |
EA201691401A1 (en) | INDASOLIC COMPOUNDS AS IRAK4 INHIBITORS | |
MX2018010191A (en) | Glycosidase inhibitors. | |
MA42410B1 (en) | Oxysterols and their methods of use | |
NZ727185A (en) | Phosphatidylinositol 3-kinase inhibitors | |
MX2016016530A (en) | Phosphatidylinositol 3-kinase inhibitors. | |
TN2015000347A1 (en) | AZABENZIMIDAZOLES AS INHIBITORS OF PDE4 ISOENZYMES FOR THE TREATMENT OF CNS DISORDERS AND OTHER DISORDERS | |
MA40225A (en) | SUBSTITUTED DIHYDROISOQUINOLINONE COMPOUNDS | |
NZ726638A (en) | Phosphatidylinositol 3-kinase inhibitors | |
MX2016016528A (en) | Phosphatidylinositol 3-kinase inhibitors. | |
MX2016016538A (en) | Quinazolinone derivatives as phosphatidylinositol 3-kinase inhibitors. | |
GEP20227353B (en) | Tetracyclic heterocycle compounds useful as hiv integrase inhibitors | |
MA39315A1 (en) | Pyridazine derivatives for use in the prevention or treatment of ataxic disorder | |
PH12021550743A1 (en) | Boron containing pde4 inhibitors | |
EA201692557A1 (en) | CINOLYSINUM DERIVATIVES AS PI3K INHIBITORS | |
MA42776B1 (en) | Compounds useful for inhibiting t-ror | |
MA44383B1 (en) | A derivative of 4- (3-pyrazolylamino) -benzimidazole as a jak1 inhibitor for the treatment of cancer | |
NZ748942A (en) | Pyrazolylaminobenzimidazole derivatives as jak inhibitors | |
MA39204B1 (en) | Heteroaryl derivatives inhibiting vps34 and / or p13 for the treatment of proliferative, inflammatory or cardiovascular disorders |